Galenica Sante Financials
| GALE Stock | CHF 79.65 0.65 0.82% |
Galenica |
Understanding current and past Galenica Sante Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Galenica Sante's financial statements are interrelated, with each one affecting the others. For example, an increase in Galenica Sante's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Galenica Sante's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Galenica Sante AG. Check Galenica Sante's Beneish M Score to see the likelihood of Galenica Sante's management manipulating its earnings.
Galenica Sante Stock Summary
Galenica Sante competes with VAT Group, Baloise Holding, Swiss Life, Helvetia Holding, and Cembra Money. Galenica AG operates as a healthcare provider in Switzerland and internationally. The company was incorporated in 2017 and is headquartered in Bern, Switzerland. Galenica Sant operates under Biotechnology classification in Switzerland and is traded on Switzerland Exchange. It employs 77 people.| Foreign Associate | USA |
| Instrument | Switzerland Stock View All |
| Exchange | SIX Swiss Exchange |
| ISIN | CH0360674466 |
| Business Address | Untermattweg 8, Bern, |
| Sector | Healthcare |
| Industry | Biotechnology |
| Benchmark | Dow Jones Industrial |
| Website | www.galenica.com |
| Phone | 41 58 852 81 11 |
| Currency | CHF - Swiss Franc |
You should never invest in Galenica Sante without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Galenica Stock, because this is throwing your money away. Analyzing the key information contained in Galenica Sante's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Galenica Sante Key Financial Ratios
There are many critical financial ratios that Galenica Sante's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Galenica Sante AG reports annually and quarterly.| Return On Equity | 0.15 | |||
| Return On Asset | 0.0492 | |||
| Target Price | 70.0 | |||
| Beta | 0.19 | |||
| Z Score | 4.6 |
Galenica Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Galenica Sante's current stock value. Our valuation model uses many indicators to compare Galenica Sante value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Galenica Sante competition to find correlations between indicators driving Galenica Sante's intrinsic value. More Info.Galenica Sante AG is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers reporting about 0.33 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Galenica Sante AG is roughly 3.07 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Galenica Sante's earnings, one of the primary drivers of an investment's value.Galenica Sante AG Systematic Risk
Galenica Sante's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Galenica Sante volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Beta measures systematic risk based on how returns on Galenica Sante AG correlated with the market. If Beta is less than 0 Galenica Sante generally moves in the opposite direction as compared to the market. If Galenica Sante Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Galenica Sante AG is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Galenica Sante is generally in the same direction as the market. If Beta > 1 Galenica Sante moves generally in the same direction as, but more than the movement of the benchmark.
Galenica Sante March 23, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Galenica Sante help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Galenica Sante AG. We use our internally-developed statistical techniques to arrive at the intrinsic value of Galenica Sante AG based on widely used predictive technical indicators. In general, we focus on analyzing Galenica Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Galenica Sante's daily price indicators and compare them against related drivers.
| Downside Deviation | 1.83 | |||
| Information Ratio | 0.172 | |||
| Maximum Drawdown | 8.99 | |||
| Value At Risk | (1.09) | |||
| Potential Upside | 1.22 |
Additional Tools for Galenica Stock Analysis
When running Galenica Sante's price analysis, check to measure Galenica Sante's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Galenica Sante is operating at the current time. Most of Galenica Sante's value examination focuses on studying past and present price action to predict the probability of Galenica Sante's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Galenica Sante's price. Additionally, you may evaluate how the addition of Galenica Sante to your portfolios can decrease your overall portfolio volatility.